Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Depreciation & Amortization (CF) (2016 - 2026)

Champions Oncology has reported Depreciation & Amortization (CF) over the past 17 years, most recently at $341000.0 for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (CF) fell 14.32% year-over-year to $341000.0; the TTM value through Jan 2026 reached $1.4 million, down 14.86%, while the annual FY2025 figure was $1.6 million, 12.16% down from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 was $341000.0 at Champions Oncology, down from $357000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $583000.0 in Q2 2023 and troughed at $341000.0 in Q1 2026.
  • A 5-year average of $457235.3 and a median of $449000.0 in 2024 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): soared 87.46% in 2022 and later dropped 21.61% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $560000.0 in 2022, then fell by 13.57% to $484000.0 in 2023, then dropped by 17.56% to $399000.0 in 2024, then fell by 10.53% to $357000.0 in 2025, then fell by 4.48% to $341000.0 in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for CSBR at $341000.0 in Q1 2026, $357000.0 in Q4 2025, and $358000.0 in Q3 2025.